Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action.
Dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 (DAX-1) is an orphan nuclear receptor that has been demonstrated to be instrumental to the expression of the steroidogenic acute regulatory (StAR) protein that regulates steroid biosynthesis in steroidogenic cells. However, its mechanism of action remains obscure. The present investigation was aimed at exploring the molecular involvement of DAX-1 in protein kinase A (PKA)- and protein kinase C (PKC)-mediated regulation of StAR expression and its concomitant impact on steroid synthesis using MA-10 mouse Leydig tumor cells. We demonstrate that activation of the PKA and PKC pathways, by a cAMP analog dibutyryl (Bu)2cAMP [(Bu)2cAMP] and phorbol 12-myristate 13-acetate (PMA), respectively, markedly decreased DAX-1 expression, an event that was inversely correlated with StAR protein, StAR mRNA, and progesterone levels. Notably, the suppression of DAX-1 requires de novo transcription and translation, suggesting that the effect of DAX-1 in regulating StAR expression is dynamic. Chromatin immunoprecipitation studies revealed the association of DAX-1 with the proximal but not the distal region of the StAR promoter, and both (Bu)2cAMP and PMA decreased in vivo DAX-1-DNA interactions. EMSA and reporter gene analyses demonstrated the functional integrity of this interaction by showing that DAX-1 binds to a DNA hairpin at position -44/-20 bp of the mouse StAR promoter and that the binding of DAX-1 to this region decreases progesterone synthesis by impairing transcription of the StAR gene. In support of this, targeted silencing of endogenous DAX-1 elevated basal, (Bu)2cAMP-, and PMA-stimulated StAR expression and progesterone synthesis. Transrepression of the StAR gene by DAX-1 was tightly associated with expression of the nuclear receptors Nur77 and steroidogenic factor-1, demonstrating these factors negatively modulate the steroidogenic response. These findings provide insight into the molecular events by which DAX-1 influences the PKA and PKC signaling pathways involved in the regulation of the StAR protein and steroidogenesis in mouse Leydig tumor cells.
Manna
Pulak R
PR
Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA.
Dyson
Matthew T
MT
Jo
Youngah
Y
Stocco
Douglas M
DM
D000818:Animals; D002843:Chromatin / Q000235:genetics; D002874:Chromosome Mapping; D017868:Cyclic AMP-Dependent Protein Kinases / Q000235:genetics / Q000378:metabolism*; D057137:DAX-1 Orphan Nuclear Receptor; D017931:DNA Primers; D004268:DNA-Binding Proteins / Q000235:genetics; D012734:Disorders of Sex Development; D005260:Female; D007984:Leydig Cell Tumor / Q000235:genetics*; D008297:Male; D051379:Mice; D010750:Phosphoproteins / Q000235:genetics*; D011493:Protein Kinase C / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013256:Steroids / Q000096:biosynthesis; D014960:X Chromosome / Q000235:genetics*; D000098682:Steroidogenic Acute Regulatory Protein
D002843:Chromatin; D057137:DAX-1 Orphan Nuclear Receptor; D017931:DNA Primers; D004268:DNA-Binding Proteins; C539966:Nr0b1 protein, mouse; D010750:Phosphoproteins; D013256:Steroids; D000098682:Steroidogenic Acute Regulatory Protein; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C
Mol Endocrinol. 2004 Jul;18(7):1610-9
15118069
Endocr Rev. 1996 Jun;17(3):221-44
8771357
J Biol Chem. 1999 Feb 26;274(9):5909-18
10026215
J Biol Chem. 2002 Sep 6;277(36):33001-11
12082103
Steroids. 2003 Dec;68(14):1125-34
14643873
Eur J Pharmacol. 2005 May 23;516(1):85-92
15913598
FEBS Lett. 1997 Feb 3;402(2-3):121-3
9037179
Steroids. 1997 Jan;62(1):5-9
9029708
J Biol Chem. 1997 Dec 19;272(51):32656-62
9405483
Biol Reprod. 2003 Jan;68(1):114-21
12493702
Mol Endocrinol. 2004 Aug;18(8):1929-40
15155786
Endocrinology. 2005 Feb;146(2):861-9
15498889
J Biol Chem. 2000 Nov 3;275(44):34719-27
10940312
J Biol Chem. 2000 Mar 17;275(11):7662-7
10713076
J Biol Chem. 1990 Mar 25;265(9):5267-72
2156866
Nature. 1997 Nov 20;390(6657):311-5
9384387
Mol Endocrinol. 1993 Sep;7(9):1196-204
8247022
Biochemistry. 1997 Jun 10;36(23):7249-55
9188726
J Endocrinol. 2007 Apr;193(1):53-63
17400803
Dev Dyn. 2001 Apr;220(4):363-76
11307169
Blood. 2003 Apr 15;101(8):3042-8
12506026
Endocrinology. 1999 Apr;140(4):1739-51
10098511
Curr Drug Targets Immune Endocr Metabol Disord. 2005 Mar;5(1):93-108
15777208
Biol Reprod. 2008 Feb;78(2):267-77
17989356
Endocrinology. 1998 Oct;139(10):4237-43
9751505
Endocrinology. 2001 Dec;142(12):5116-23
11713204
Mol Endocrinol. 2004 Apr;18(4):791-806
14726488
Mol Endocrinol. 2006 Feb;20(2):362-78
16166197
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12441-5
8618917
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7250-5
10377400
Int J Urol. 2006 Jun;13(6):785-93
16834661
J Biol Chem. 2004 Mar 5;279(10):8938-45
14688288
Mol Cell Biol. 1997 Mar;17(3):1476-83
9032275
Mol Endocrinol. 1997 Jan;11(1):39-47
8994186
J Mol Endocrinol. 2003 Jun;30(3):381-97
12790807
Mol Endocrinol. 2007 Mar;21(3):589-601
16973755
Endocrinology. 1997 Nov;138(11):4893-901
9348220
Mol Endocrinol. 1997 Feb;11(2):138-47
9013761
Endocrine. 1999 Feb;10(1):83-91
10403575
Mol Endocrinol. 2002 Jan;16(1):184-99
11773448
J Biol Chem. 2002 Feb 1;277(5):3293-302
11719525
Mol Cell Endocrinol. 2004 Sep 30;224(1-2):29-39
15353178
J Mol Endocrinol. 2006 Aug;37(1):81-95
16901926
Mol Genet Metab. 2005 Sep-Oct;86(1-2):70-83
16146703
J Biol Chem. 2002 Oct 25;277(43):41259-67
12186872
Mol Endocrinol. 1997 Dec;11(13):1950-60
9415399
Arch Med Res. 2001 Nov-Dec;32(6):576-86
11750733
J Biol Chem. 1999 Jun 18;274(25):17987-96
10364248
Endocrinology. 2002 Sep;143(9):3351-60
12193547
Endocrine. 2006 Dec;30(3):313-23
17526944
Nat Genet. 2003 May;34(1):32-3
12679814
Endocrinology. 2001 Dec;142(12):5097-106
11713202
Mol Cell Biol. 2000 Jul;20(13):4910-21
10848616
Nature. 1994 Dec 15;372(6507):635-41
7990953
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
12824337
J Mol Endocrinol. 2007 Oct;39(4):261-77
17909266
Mol Endocrinol. 1996 Dec;10(12):1561-9
8961266
Int J Biochem Cell Biol. 2005 Jan;37(1):214-23
15381163
Science. 1995 Mar 24;267(5205):1828-31
7892608
Mol Endocrinol. 2008 Sep;22(9):2021-37
18599618
J Biol Chem. 1994 Nov 11;269(45):28314-22
7961770
Endocrinology. 1999 Sep;140(9):3919-27
10465260
Mol Cell Biol. 2002 Oct;22(20):7193-203
12242296
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):92-101
16682116
Biol Reprod. 2001 Apr;64(4):1191-9
11259267
Nucleic Acids Res Suppl. 2002;(2):95-6
12903122
Endocrinology. 2000 Apr;141(4):1345-55
10746638
Exp Cell Res. 2001 Jan 15;262(2):95-103
11139333
Mol Endocrinol. 2005 Nov;19(11):2647-59
15831519
Biol Reprod. 2005 Aug;73(2):244-55
15814901
Biochem J. 2000 Oct 1;351(Pt 1):95-105
10998351
Endocrinology. 1981 Jan;108(1):88-95
6257492
Mol Endocrinol. 2004 Mar;18(3):558-73
14673133
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7988-93
11427738
J Clin Endocrinol Metab. 2003 May;88(5):2288-99
12727988
J Clin Endocrinol Metab. 1999 Feb;84(2):504-11
10022408
Mol Endocrinol. 2001 Jan;15(1):57-68
11145739
Endocrinology. 2004 Dec;145(12):5629-37
15358680
Nature. 1994 Dec 15;372(6507):672-6
7990958
Mol Endocrinol. 2003 Aug;17(8):1445-53
12775766
Endocrinology. 2001 Jan;142(1):319-31
11145595
Biochem Pharmacol. 2004 Nov 15;68(10):1923-8
15476663
Mol Cell Biol. 1998 May;18(5):2949-56
9566914
J Biol Chem. 2001 Sep 14;276(37):34888-95
11410589
Endocrinology. 2005 Mar;146(3):1348-56
15550512
Mol Endocrinol. 2002 Jul;16(7):1638-51
12089357